BioForce Nanosciences (OTCMKTS:BFNH) Shares Down 35% – Should You Sell?

BioForce Nanosciences Holdings, Inc. (OTCMKTS:BFNHGet Free Report) dropped 35% during trading on Thursday . The company traded as low as $0.58 and last traded at $0.58. Approximately 7,815 shares were traded during mid-day trading, an increase of 140% from the average daily volume of 3,250 shares. The stock had previously closed at $0.90.

BioForce Nanosciences Price Performance

The firm has a market cap of $14.93 million, a P/E ratio of -51.00 and a beta of -1.40. The company’s 50-day moving average is $0.98 and its two-hundred day moving average is $1.12.

BioForce Nanosciences Company Profile

(Get Free Report)

BioForce Nanosciences Holdings, Inc focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels.

Featured Articles

Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.